Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zanidip vs Felodipine in Mild-to-Moderate Hypertension
NCT01520285Phase 4Completed
- Sponsor
- Lee's Pharmaceutical Holdings Limited
- Start
- Dec 2011
- Primary completion
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of lercanidipine in hypertension (HTN) (2 arms), sponsored by Lee's Pharmaceutical Holdings Limited. Primary endpoint: Change from baseline in mean seated diastolic blood pressure at 6 weeks. Started Dec 2011; status: completed.
02
Drugs
lercanidipine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT01520285.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01520285.